Summary by Futu AI
CHINA PHARMACEUTICAL HOLDINGS LIMITED WILL HOLD ITS ANNUAL GENERAL MEETING ON 14 JUNE 2024 IN FOSHAN, GUANGDONG PROVINCE, TO REVIEW AND CONSIDER AUDITED FINANCIAL STATEMENTS, BOARD REPORTS AND INDEPENDENT AUDITOR REPORTS FOR THE YEAR ENDED 31 DECEMBER 2023. The Board will re-elect the Board of Directors, including Ms. Li Ju, Mr. Yang Binghua, Mr. Tse Wing and Mr. Lee Wai Dong, and authorize the Board to determine the directors' remuneration. In addition, EY Accounting Firm will seek reappointment as company auditor, and the Board of Directors will be empowered to determine their remuneration. In order to ensure that shareholders can attend and vote, the registration of the Company's shares will be suspended from 11 to 14 June 2024. DETAILS OF THE RE-ELECTION OF DIRECTORS AND AUDITORS WILL BE SENT TO SHAREHOLDERS ON 23 MAY 2024. Currently, the Board consists of eleven directors, including Mr. Chen Yinglong, Executive Director, and other non-executive and independent non-executive directors.